Covid-19 Vaccination Programme phase 3 outline
For the 2021 COVID-19 booster vaccine programme individuals who received vaccination in Phase 1 of the COVID-19 vaccination programme (priority groups 1 to 9) should be offered a third dose COVID-19 booster vaccine.
- those living in residential care homes for older adults
- all adults aged 50 years or over
- frontline health and social care workers
- all those aged 16 to 49 years with underlying health conditions that put them at higher risk of severe COVID-19 (as set out in the green book), and adult carers
- adult household contacts (aged 16 or over) of immunosuppressed individuals
As most younger adults will only have received their second COVID-19 vaccine dose in late summer or early autumn, the benefits of booster vaccination in this group will be considered at a later time when more information is available. In general, younger, healthy individuals may be expected to generate stronger vaccine-induced immune responses from primary course vaccination compared to older individuals. Pending further evidence otherwise, booster doses in this population may not be required in the near term.
JCVI advice is that the Covid-19 booster can be given together, at the same time as the flu vaccine.
Phase 3 of the Covid-19 vaccination programme, primarily focused on the delivery of a booster vaccine, is due to begin in September 2021, with the aim to maximise protection in those who are most vulnerable to serious Covid-19 ahead of the winter months. Influenza (flu) vaccines are also delivered in the autumn months. The Joint Committee on Vaccination and Immunisation (JCVI) have considered this and state that where possible, a combined approach to the delivery of Covid-19 and influenza vaccination could support the delivery and maximise uptake of both vaccines.
It's important to note that within phase 3 of the programme is the offer of a first dose of the Covid-19 vaccine to 12-15 year olds, and the continuation of an offer to those who are eligible but are yet to take up a first or second dose of the vaccine.